Zantac Breast Cancer Cases Reviewed Nationwide

Millions of women have taken Zantac (ranitidine) for the treatment of heartburn and acid reflux. While the drug makers indicated that the drug was safe and effective, recent evidence suggests that the active ingredient may convert to a toxic chemical by product known as N-Nitrosodimethylamine (NDMA).

Contact Our Lawyers to Review aZANTAC BREAST CANCER CASE

  • Do You Have a Valsartan Case?
  • Step 1 of 2

Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD

This potent carcinogen may have exposed women throughout the United States to an increased risk of different types of breast cancer from Zantac side effects, including:

  • Ductal Carcinoma In Situ
  • Invasive Ductal Carcinoma
  • Invasive Lubular Carcinoma
  • Inflammatory Breast Cancer
  • Lubular Carcinoma In Situ
  • Metastatic Breast Cancer

The Zantac breast cancer lawyers at Saiontz & Kirk, P.A. provide free consultations and claim evaluations for women and families nationwide. All cases are reviewed on a contingency fee basis, which means that there are no out-of-pocket costs to hire our law firm and we only receive attorney fees or expense if a Zantac settlement or recovery is obtained.

Find Out If You Have a Breast Cancer Lawsuit

Zantac and Breast Cancer Risk

Zantac (ranitidine) was introduced in 1983, as the first member of a new class of medications, known as histamine H2-receptor antagonists (H2 blockers). It has been widely marketed as a safe treatment for heartburn, acid indigestion, sour stomach, gastroesophageal reflux disease (GERD) and other conditions. However, it now appears that Zantac side effects may carry serious cancer risks, including an increased risk of breast cancer.

The active ingredient in Zantac is ranitidine, which has an inherent molecular structure that may react with itself. This can produce dangerous levels of the chemical N-Nitrosodimethylamine (NDMA) when exposed to high temperatures inside the human body or during transport (such as in a hot car).

For decades, NDMA has been known to increase the risk of cancer in humans. While the drug makers knew or should have known about the link between Zantac and cancer, they failed to adequately research the risk or warn users and the medical community.

Following exposure for only a few months, experts indicate that NDMA may result in the development of breast cancer from Zantac.

Zantac Cancer RisksExposure to NDMA in Zantac may cause users to face an increased risk of several different types of cancer, including::

  • Breast Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Esophageal Cancer
  • Liver Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Colorectal Cancer
  • Lung Cancer

Zantac Recall Issued For All Versions of Ranitidine in April 2020

Between September 2019 and early 2020, a number of individual ranitidine-based drugs were removed from the market, as manufacturers confirmed that unacceptable levels of NDMA were detected in pills.

These actions came after a Citizen’s Petition (PDF) called for the FDA to recall Zantac, due to the discovery that high levels of NDMA were in Zantac and generic ranitidine pills manufactured by many different drug makers.

Following months of speculation, the FDA requested that all manufacturers issue Zantac recalls in April 2020, after determining that the continued sale of the medication posed an unreasonable risk for consumers.

Since the the NDMA levels in Zantac can increase over time, particularly when the drug is stored at higher temperatures, the regulatory agency determined that it was necessary to remove all forms of Zantac from the market.

NDMA Breast Cancer Side Effects from Zantac

For decades NDMA has been known to increase the risk of humans, and the only current use of the chemical is to induce tumors in lab rats during clinical studies.

While research on the link between Zantac and breast cancer is continuing, prior studies have established that the drug makers knew or should have known about this potential risk, yet withheld warnings from consumers and the medical community.

NDMA exposure From Zantac may increase risk of breast cancer and other side effects.

In 2018, a study published in the medical journal Cancer Epidemiology, Biomarkers & Prevention examined the relationship between breast cancer and H2 Blockers like Zantac (ranitidine).

While researchers concluded generally that the class of medications does not increase the risk of breast cancer, serious concerns were highlighted about the potential Zantac risks. The study concluded that use of ranitidine may increase the risk of hormone-receptor-positive ductal carcinoma breast cancer, calling for further studies to be conducted.

Although the manufacturers knew or should have known about the potential link between breast cancer and Zantac side effects, users and the medical community have not been advised of this potential risk. As a result, financial compensation and breast cancer settlements may be available for women nationwide.

Zantac Breast Cancer Lawsuit Allegations

The lawyers at Saiontz & Kirk, P.A. are reviewing potential Zantac class action lawsuits and individual claims for women diagnosed with breast cancer. Wrongful death claims are also being evaluated for families of those who previously died as a result of breast cancer caused by Zantac. According to allegations presented in these lawsuits, the drug makers:

  • Failed to properly research the breast cancer side effects of Zantac before introducing the drug;
  • Knew or should have discovered that Zantac exposes users to an unsafe level of the carcinogen NDMA;
  • Failed to warn about the potential breast cancer risk from Zantac;
  • Failed to promptly issue Zantac recalls or safety warnings for users and the medical community.

No Fees or Expenses Unless You Receive a Zantac Breast Cancer Settlement

Saiontz & Kirk, P.A. is a nationally known injury law firm that is focused exclusively on representing individuals, we do not represent corporations or insurance companies.

Over the course of more than 40 years, clients of our law firm have collected more than $1 billion in compensation in cases involving product liability, medical malpractice, automobile accidents and other personal injury lawsuits.

All Zantac breast cancer cases are being handled on a contingency fee basis, which means that there are never any out-of-pocket costs to hire our lawyers and we receive no fees or expenses unless a recovery is obtained. Individual claims are also being pursued for individuals diagnosed with:

  • Prostate Cancer
  • Pancreatic Cancer
  • Esophageal Cancer
  • Bladder Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer

Protect your family and find out if you or a loved one may be entitled to a Zantac settlement.

CONTACT OUR ZANTAC CANCER LAWYERS No Fees or Expenses Unless a Recovery is Obtained.

  • This field is for validation purposes and should be left unchanged.

Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD